Moderna -SARS-CoV-2 mRNA-1273 is a Phase 3, randomized, stratified, observer-blind, placebo-controlled study to evaluate the efficacy, safety, and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine compared to placebo in adults 18 years of age and older who have no known history of SARS-CoV-2 infection but whose locations or circumstances put them at appreciable risk of acquiringCOVID-19 and/or SARS-CoV-2 infection.
(This study completed enrollment in 2020 and is no longer recruiting participants. Current participants continue study follow-up.)
Interested in learning more about our studies and clinical trials?
Please let us know more about you. We will contact you for further information to determine eligibility for current and future studies.
Questions? We're here to help.
For any questions or further information, please contact us.